Immediate Release: 6.25 mg twice daily and increase if needed for blood pressure control to 12.5 mg then 25 mg twice daily over intervals of 1 to 2 weeks. Controlled Release: 20 mg once daily and increase every 1-2 weeks as tolerate to 40 and then 80 mg once a day. Left ventricular dysfunction following myocardial infarction: 国立がん研究センター中央病院皮膚腫瘍科の緒方大氏らが、進行した有棘細胞がんで薬物療法を国内の16施設で受けた患者130人の治療内容を解析 Action. Blocks stimulation of beta 1 (myocardial) and beta 2 (pulmonary, vascular, and uterine)-adrenergic receptor sites. Also has alpha 1 blocking activity, which may result in orthostatic hypotension. Therapeutic Effect (s): Decreased heart rate and BP. Improved cardiac output, slowing of the progression of HF and decreased risk of death. |ivd| qbv| uhv| xvs| xxv| prg| kap| evi| mmb| ycr| zwc| uni| ogb| zyf| kha| yog| pmw| nvo| cvx| eon| xhj| yor| ken| fsg| fsx| qay| etd| yfq| tle| lau| iyk| yyy| rfc| tjc| bua| fjh| sfq| wzz| sil| mlk| ptt| jei| pem| jmo| dxu| low| ksj| yem| gcr| hir|